Research & Development
The development of our Click Activated Protodrugs (CAP™) Platform, a new therapeutic modality based on click chemistry, utilizes the biocompatible chemical reaction between an attenuated trans-cyclooctene-modified protodrug and a tetrazine-modified biopolymer.
This platform can be used with various treatments to deliver drugs to treat many diseases and conditions.